The core activity of Deep Breath Intelligence AG (DBI) is the development and application of breath analysis technologies for the healthcare and pharmaceutical industries. DBI offers clinical trial services, analyzing breath samples to gain insights into various diseases such as epilepsy, respiratory diseases, Long Covid, lung cancer, and metabolic disorders. The company also develops products like the DBI-EPIbreath system, used for breath analysis and disease detection. DBI collaborates closely with pharma and healthtech companies to advance precision medicine through innovative breath analysis technologies.